Agents with antialdosterone properties should be the preferred diuretics for reducing hypertension related atrial fibrillation

European Journal of Internal Medicine

Volumn 21, Issue 1, 2010, Pages 55-

  Jolobe, Oscar M P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBROTIC AGENT; DIURETIC AGENT; EPLERENONE; HYDROCHLOROTHIAZIDE; THIAZIDE DIURETIC AGENT; TORASEMIDE;

BLOOD PRESSURE; DRUG EFFICACY; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HYPERTENSION; LETTER;

ANTIHYPERTENSIVE AGENTS; ATRIAL FIBRILLATION; DIURETICS; HUMANS; HYPERTENSION; SPIRONOLACTONE; SULFONAMIDES;

EID: 73549118782     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2009.05.001     Document Type: Letter

References (4)

1. Sassano P., Chatellier G., Billaud E., Corvol P., and Menard J. Comparison of increase in the enalapril dose and addition of hydrochlorothiazide as second step treatment of hypertensive patients not controlled by enalapril alone. J Cardiovasc Pharmacol 13 (1989) 314-319
2. Lopez B., Querejeta R., Gonzalez A., Sanchez E., Larman M., and Diez J. Effects of loop diuretics on myocardial fibrosis and collagen Type 1 turnover in chronic heart failure. J Am Coll Cardiol 43 (2004) 2028-2035
3. Casaclang-Verosa G., Gersh B.J., and Tsang T.S.M. Structural and functional remodeling of the left atrium. J Am Coll Cardiol 52 (2008) 1-11
4. Solun B., Marcoviciu D., and Dicker D. Does treatment of hypertension decrease the incidence of atrial fibrillation and cardioembolic stroke?. Eur J Intern Med 20 (2009) 125-131